Sarah Hoffner is currently the Associate Director of Market Assessment and New Product Planning at LEO Pharma, a position they have held since 2025. Previously, they worked as a Commercial Strategy Lead at Lexeo Therapeutics and served in multiple roles at Entrée Health, culminating as Vice President, Account Group Supervisor. In 2023, they gained experience as an Investment Banking Summer Associate at J.P. Morgan. Sarah is pursuing a Bachelor of Arts in Medicine, Health and Society and History at Vanderbilt University and is also enrolled in the MBA program at Harvard Business School, expected to conclude in 2024.
This person is not in the org chart
This person is not in any teams
This person is not in any offices